ReviewCurrent opinion in allergy and clinical immunology2019

Prostaglandin E2 in NSAID-exacerbated respiratory disease: protection against cysteinyl leukotrienes and group 2 innate lymphoid cells.

Mark Rusznak et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.